Milea Timbergen

143 References 1 . Fletcher CDM. WHO classification of tumours of soft tissue and bone. Lyon: IARC; 2013. 2 . van Broekhoven DL, Grunhagen DJ, den Bakker MA, van Dalen T, Verhoef C. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study. Ann Surg Oncol. 2015;22(9):2817-2823. 3 . Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982;77(6):665-673. 4 . Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, Tirumani SH, Shinagare AB, Hornick JL, et al. Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics. 2016;36(3):767-782. 5 . Walker EA, Fenton ME, Salesky JS, Murphey MD. Magnetic resonance imaging of benign soft tissue neoplasms in adults. Radiol Clin North Am. 2011;49(6):1197-1217. 6 . Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 2005;18(1):68-74. 7 . Enzo MV, Cattelan P, Rastrelli M, Tosi A, Rossi CR, Hladnik U, et al. Growth rate and myofibroblast differentiation of desmoid fibroblast-like cells are modulated by TGF-β signaling. Histochem Cell Biol. 2019;151(2):145-160. 8 . Colombo C, Miceli R, Lazar AJ, Perrone F, Pollock RE, Le Cesne A, et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer. 2013;119(20):3696-3702. 9 . Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173(5):1518-1527. 10 . van Broekhoven DL, Verhoef C, Grunhagen DJ, van Gorp JM, den Bakker MA, Hinrichs JW, et al. Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol. 2015;22(5):1464-1470. 11 . Crago AM, Chmielecki J, Rosenberg M, O’Connor R, Byrne C, Wilder FG, et al. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes Chromosomes Cancer. 2015;54(10):606-615. 12 . Timbergen MJM, Colombo C, Renckens M, Kim HS, Rosmalen JV, Salas S, et al. The Prognostic Role of beta-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data. Ann Surg. 2019. Online, ahead of print. 13 . Group DTW. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer. 2020;127:96-107. 14 . Starmans MPA, van der Voort SR, Tovar JMC, Veenland JF, Klein S, Niessen WJ. Radiomics: Data mining using quantitative medical image features. Handbook of Medical Image Computing and Computer Assisted Intervention: Elsevier; 2020. p. 429-456. 15 . Rutman AM, Kuo MD. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. Eur J Radiol. 2009;70(2):232-241. 16 . Mazurowski MA. Radiogenomics: what it is and why it is important. J AmColl Radiol. 2015;12(8):862-866. 17 . Bodalal Z, Trebeschi S, Nguyen-Kim TDL, Schats W, Beets-Tan R. Radiogenomics: bridging imaging and genomics. Abdom Radiol (NY). 2019;44(6):1960-1984. 18 . Otero S, Moskovic EC, Strauss DC, Benson C, Miah AB, Thway K, et al. Desmoid-type fibromatosis. Clinical Radiology. 2015;70(9):1038-1045. 19 . Smith HG, Tzanis D, Messiou C, Benson C, van der Hage JA, Fiore M, et al. The management of soft tissue tumours of the abdominal wall. Eur J Surg Oncol. 2017;43(9):1647-1655. 20 . Zou KH, Warfield SK, Bharatha A, Tempany CMC, Kaus MR, Haker SJ, et al. Statistical validation of image segmentation quality based on a spatial overlap index1: scientific reports. Academic Radiology. 2004;11(2):178-189. 5